Association of FcRn expression with lung abnormalities and IVIG catabolism in patients with common variable immunodeficiency
Language English Country United States Media print
Document type Journal Article, Research Support, Non-U.S. Gov't
PubMed
20627700
DOI
10.1016/j.clim.2010.05.006
PII: S1521-6616(10)00583-8
Knihovny.cz E-resources
- MeSH
- Common Variable Immunodeficiency genetics immunology pathology physiopathology MeSH
- Adult MeSH
- Gene Expression MeSH
- Phenotype MeSH
- Immunoglobulin G blood MeSH
- Immunoglobulins, Intravenous blood MeSH
- Middle Aged MeSH
- Humans MeSH
- RNA, Messenger genetics metabolism MeSH
- Histocompatibility Antigens Class I genetics MeSH
- Minisatellite Repeats MeSH
- Adolescent MeSH
- Young Adult MeSH
- Lung immunology pathology physiopathology MeSH
- Promoter Regions, Genetic MeSH
- Receptors, Fc genetics MeSH
- Aged MeSH
- Check Tag
- Adult MeSH
- Middle Aged MeSH
- Humans MeSH
- Adolescent MeSH
- Young Adult MeSH
- Male MeSH
- Aged MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Names of Substances
- Fc receptor, neonatal MeSH Browser
- Immunoglobulin G MeSH
- Immunoglobulins, Intravenous MeSH
- RNA, Messenger MeSH
- Histocompatibility Antigens Class I MeSH
- Receptors, Fc MeSH
The neonatal Fc receptor (FcRn) acts as a key regulator of IgG homeostasis and is an important sensor of luminal infection. We analyzed the influence of FcRn expression on disease phenotype and the catabolism of therapeutically administered intravenous immunoglobulins (IVIG) in 28 patients with common variable immunodeficiency (CVID). Patients with generalized bronchiectasis and fibrosis had lower levels of FCRN mRNA compared to patients without these complications (P=0.027 and P=0.041, respectively). Moreover, FCRN mRNA levels correlated negatively with the extent of bronchiectasis and the rate of IgG decline after infusion of IVIG (P=0.027 and P=0.045, respectively). No relationship of FCRN expression with age at disease onset, age at diagnosis, diagnostic delay, IgG levels or frequency of infections before or during replacement immunoglobulin treatment, the presence of lung functional abnormalities, chronic diarrhea, granulomas, lymphadenopathy, splenomegaly or autoimmune phenomena was observed. Our results showed that FcRn might play a role in the development of lung structural abnormalities and in the catabolism of IVIG in patients with CVID.
References provided by Crossref.org